Is It Safe to Use a TENS Unit With AFib?

Using a TENS unit when you have atrial fibrillation depends heavily on one critical detail: whether you also have an implanted cardiac device such as a pacemaker or defibrillator. If your AFib is managed with medication alone and you have no implanted hardware, the safety profile looks very different than it does for someone with an ICD or pacemaker. That distinction matters more than almost anything else in answering this question, yet it often gets lost in blanket warnings.

The Real Concern Is Implanted Devices, Not AFib Itself

Most of the safety warnings you encounter about TENS and heart conditions trace back to one specific problem: electromagnetic interference (EMI) with implanted cardiac devices. A TENS unit sends small electrical pulses through the skin to relieve pain, and those pulses can sometimes be picked up by the sensors inside a pacemaker or implantable cardioverter-defibrillator (ICD). The device’s electronics can misread those external pulses as cardiac signals, potentially leading to inappropriate responses like unnecessary shocks or disrupted pacing.

Patients with pacemakers and ICDs are generally advised to avoid electrical stimulation devices because EMI can cause the implanted device to fail to detect a real arrhythmia or, conversely, to misinterpret the TENS signal as a dangerous heart rhythm that needs intervention.¹ If you have AFib but no implanted device, this particular concern does not apply to you. The issue is not that TENS triggers arrhythmias in an otherwise normal heart; it is that the electrical signal confuses the implanted hardware monitoring the heart.

How Often Interference Actually Happens

A study published in EP Europace tested 107 patients with implanted defibrillators while applying TENS at various body locations. Electromagnetic interference was detected in about 16% of those patients. The most common problem was the ICD misreading the TENS signal as a premature heartbeat, which occurred in roughly 14% of patients. In a smaller number, the device interpreted the signal as noise and temporarily switched to asynchronous pacing. In two patients, the ICD mistakenly classified the interference as ventricular tachycardia or ventricular fibrillation, which are the rhythms that trigger a shock.²

Where you place the electrodes matters enormously. Interference was far more common when the TENS pads were placed on the chest compared to the neck area. Right ventricular sensing artifacts occurred in about 13% of patients during chest-level TENS versus less than 1% during cervical spine application. Higher current intensity also increased the likelihood of interference, as did the specific manufacturer of the implanted device.³

These numbers are worth sitting with for a moment. A 16% interference rate is not trivial, but it also means that in roughly 84% of patients the ICD had no problem at all. The severity of the interference varied widely, from clinically harmless misreads to potentially dangerous false detections of life-threatening rhythms. This range helps explain why some clinicians allow supervised TENS use in patients with implanted devices while others advise against it entirely.

Even “Safe” Initial Testing Can Fail Later

One of the more unsettling findings in this area comes from a case involving a patient with a biventricular ICD. Initial testing showed no interference between the TENS unit and the implanted device, so the patient was cleared to use it for chronic pain. Six months later, the patient developed dizziness and abnormally slow heart rate during TENS sessions. Repeat testing then revealed interference with pacemaker function that had not been present earlier.⁴

The authors concluded that even with negative initial testing, patients with biventricular ICDs need careful ongoing follow-up and should be cautioned against TENS use, especially if they depend on the pacing function. This finding matters because it undermines the reassurance of a single supervised test session. Conditions inside the body change: lead positions shift slightly, scar tissue develops around electrodes, and the TENS unit’s electrode pads degrade over time. All of these can alter whether interference occurs.

AFib Without an Implanted Device

If you have AFib managed by medication, cardioversion, or ablation and you do not have a pacemaker or ICD, the electromagnetic interference concern is off the table. There is no implanted sensor to confuse. The relevant question then shifts to whether TENS can affect your heart rhythm through other pathways, and the evidence here is more reassuring, though not entirely clean.

Standard TENS for pain relief sends current through the skin between two electrode pads placed near the painful area. The electrical field is shallow and localized. When the pads are placed on a limb or the lower back, the current path does not pass through or near the heart. Placing electrodes on the chest, across the chest, or near the neck brings the current closer to the heart and the major nerves that influence heart rhythm, which is why virtually every TENS unit manual warns against electrode placement directly over or across the chest.

No published evidence links standard TENS use on the extremities to the triggering of new AFib episodes in people without implanted devices. That said, the research specifically examining TENS safety in AFib patients without devices is thin. Much of the available literature focuses on implanted device interactions because that is where the documented harm has occurred. The absence of evidence is not the same as evidence of absence, but the theoretical risk of a TENS unit on your knee or lower back affecting your heart rhythm is very low based on what we understand about the current pathways involved.

How TENS Shifts the Nervous System Balance

Your heart rhythm is governed in part by the balance between two branches of the autonomic nervous system: the sympathetic branch, which speeds the heart up, and the parasympathetic branch, which slows it down. TENS has been shown to influence this balance, and the direction of the shift depends on the frequency of the stimulation.

In a study of healthy volunteers, low-frequency TENS (around 10 Hz) reduced sympathetic activity and boosted parasympathetic activity. High-frequency TENS (100 Hz) did the opposite, increasing sympathetic tone and reducing parasympathetic activity.⁵ A separate randomized trial in hypertensive patients confirmed this pattern: 4 Hz TENS shifted the autonomic balance toward parasympathetic dominance, while 100 Hz TENS and placebo produced no significant changes.⁶

For someone with AFib, this autonomic modulation is a double-edged sword. Some AFib is triggered by high vagal (parasympathetic) tone, particularly in younger, otherwise healthy individuals whose episodes tend to occur at rest or during sleep. For these people, low-frequency TENS that boosts parasympathetic activity could theoretically nudge things in the wrong direction. Other AFib is driven by high sympathetic tone, occurring during exercise or stress, and might theoretically benefit from a parasympathetic shift. The reality is that we do not have clinical trials testing these scenarios directly in AFib patients using standard pain-relief TENS protocols, so these remain informed speculations rather than established effects.

Vagus Nerve Stimulation for AFib Is a Different Story

You may come across research suggesting that transcutaneous electrical stimulation can actually reduce AFib burden. This research exists and is legitimate, but it involves a very different setup from a typical TENS pain unit. The TREAT AF randomized clinical trial used low-level transcutaneous electrical stimulation applied specifically to the tragus of the ear, which is innervated by the auricular branch of the vagus nerve. After six months, patients in the active stimulation group had an 85% lower median AFib burden compared to the control group, along with a significant reduction in the inflammatory marker TNF-alpha.⁷

This is exciting research, but it should not be confused with using a standard TENS unit for knee pain or backache. The TREAT AF protocol used carefully calibrated stimulation at a specific anatomical site known to activate vagal afferent fibers. A consumer TENS unit strapped to your lower back for muscle pain is not stimulating the vagus nerve in the same targeted way. Applying a standard TENS unit to your ear because you read about this trial would be inadvisable without medical supervision, as the parameters, electrode design, and monitoring involved in the research are not replicated by off-the-shelf pain devices.

TENS Can Confuse Heart Monitoring Equipment

Even if TENS does not directly affect your heart, it can create a practical problem during cardiac monitoring. The electrical pulses from a TENS unit can produce artifacts on an electrocardiogram that look startlingly like pacemaker spikes or other cardiac abnormalities. In one documented case, TENS electrodes placed on the thoracic and lumbar spine created an ECG artifact that was initially interpreted as a malfunctioning cardiac pacemaker.⁸ Another case report described TENS-related ECG artifacts consisting of low-amplitude, high-frequency deflections that mimicked a runaway pacemaker.⁹

If you have AFib and are being monitored with a Holter monitor or continuous telemetry, using a TENS unit simultaneously can produce confusing tracings that obscure the very rhythms your doctor is trying to evaluate. At a minimum, let any healthcare provider monitoring your heart know that you are using a TENS unit so they can account for potential artifacts. Better yet, turn the TENS unit off during any cardiac monitoring period.

Practical Guidelines for TENS Use With AFib

If you have AFib and are considering a TENS unit for pain management, a few practical considerations can help you and your doctor make an informed decision:

No implanted device: If your AFib is managed without a pacemaker or ICD, standard TENS applied to the extremities or lower back carries low theoretical risk. Avoid placing electrodes on or across the chest, and avoid the front of the neck.
With a pacemaker or ICD: Do not use a TENS unit without explicit clearance from your cardiologist or electrophysiologist. If approved, use should be supervised initially, and keep in mind that initial clearance does not guarantee ongoing safety.
Electrode placement: The farther the electrodes are from the heart and from any implanted device leads, the lower the risk of interference. Limbs are safer than the torso.
Intensity settings: Higher current intensity increases the risk of electromagnetic interference with implanted devices. Start at the lowest effective setting.
During monitoring: Turn off the TENS unit during any ECG, Holter recording, or telemetry monitoring to avoid artifacts that could be mistaken for cardiac abnormalities.

The single most important step is having a conversation with the clinician who manages your AFib. They know your specific situation: whether your AFib is paroxysmal or persistent, whether you have an implanted device, whether your episodes tend to be vagally mediated or sympathetically driven, and whether you are on anticoagulants or antiarrhythmics that might interact with any autonomic effects of TENS. A blanket “TENS is dangerous with heart conditions” overstates the risk for many people, but a blanket “TENS is fine” understates it for others.

Blood Pressure Effects Worth Knowing About

TENS has been shown to influence blood pressure, which is relevant if your AFib coexists with hypertension, as it commonly does. In a case report involving a patient with resistant hypertension, a course of TENS applications led to meaningful reductions in both office blood pressure and 24-hour ambulatory readings, including reductions in central blood pressure and arterial stiffness measures. The proposed mechanism was a dampening of the sympathetic hyperactivity present in resistant hypertension.¹⁰

This is a single case report, so the magnitude of the effect should not be taken as representative. But it aligns with the broader finding that TENS modulates autonomic tone. If you are taking blood pressure medications alongside AFib treatment, be aware that TENS might modestly lower your blood pressure, which could matter if you are already on the lower end of your target range. Feeling lightheaded during or after a TENS session would be worth mentioning to your doctor, particularly if you are on rate-control medications like beta-blockers that also lower blood pressure and heart rate.

Why the Research Is Limited

One reason this question is harder to answer than you might expect is that the research addressing TENS safety specifically in AFib patients is sparse. The implanted device literature is relatively robust because the mechanism of harm (electromagnetic interference) is well understood and easy to test in a controlled setting. But the question of whether TENS meaningfully affects AFib episodes in people without devices has not been directly studied in any large trial. The autonomic modulation research uses heart rate variability as a proxy for cardiac risk, which is informative but not the same as tracking actual AFib recurrence.

The vagus nerve stimulation research, while promising, uses a fundamentally different protocol than consumer TENS. And much of the broader TENS safety literature excludes cardiac patients from enrollment, creating a circular evidence gap: we do not know much about TENS in AFib patients partly because researchers have avoided enrolling them out of an abundance of caution. Until targeted trials fill this gap, clinical decisions rest on extrapolation from device-interaction studies, autonomic physiology, and the general understanding that keeping electrical current away from the heart is a reasonable precaution even when the specific risk is low.